Original Paper

Metastasis to the Pancreas: Characterization by Morphology and Contrast Enhancement Features on CT and MRI
Moritz Palmowski^{a, b}, Nicola Hacke^b, Stefanie Satzl^b, Miriam Klauss^b, Moritz N. Wente^c, Martin Neukamm^b, Joerg Kleeff^c, Peter Hallscheidt<sup>b

a</sup>Division of Medical Physics in Radiology, German Cancer Research Center, and Departments of
^bDiagnostic Radiology and
^cGeneral Surgery, University of Heidelberg, Heidelberg, Germany

Address of Corresponding Author

Pancreatology 2008;8:199-203 (DOI: 10.1159/000128556)

  Key Words

• Metastasis
• Pancreas
• Renal cell carcinoma
• Magnetic resonance imaging
• Computed tomography

  Abstract

Aims: To investigate the characteristics of metastasis to the pancreas using computed tomography (CT) and magnetic resonance imaging (MRI). Methods: Twenty-two patients with metastases to the pancreas were examined preoperatively by MRI (7/22) and/or multidetector CT (15/22). Pre- and post-contrast images were acquired and morphology, size, and contrast enhancement of the tumor analyzed. Subsequently, all patients underwent surgery, and the histopathologic findings were compared with the imaging results. Results: In 22 patients, a total of 29 metastases were found on CT and MRI. These metastases originated from renal cell carcinomas (RCC; 22/29), colorectal carcinoma (3/29), and other malignancies (4/29). The metastases differed not in size or location, but in their contrast enhancement characteristics. RCC metastases had either intense homogeneous enhancement (in small lesions) or rim enhancement (in large lesions). Outer regions of colorectal metastases showed no difference from normal pancreatic tissue, whereas the inner area showed hypo-enhancement due to central necrosis. Conclusion: Imaging features of metastases from RCC point to their primary origin. While they can be distinguished from primary adenocarcinoma of the pancreas, differentiation from endocrine carcinoma might be difficult. Differentiation of colorectal carcinoma remains to be investigated on larger numbers of cases.

Copyright © 2008 S. Karger AG, Basel and IAP

  References

1.

Roland CF, van Heerden JA: Nonpancreatic primary tumors with metastasis to the pancreas. Surg Gynecol Obstet 1989;168:345-347.

2.

Wente MN, Kleeff J, Esposito I, Hartel M, Muller MW, Frohlich BE, Buchler MW, Friess H: Renal cancer cell metastasis into the pancreas: a single-center experience and overview of the literature. Pancreas 2005;30:218-222.

3.

Sellner F, Tykalsky N, De Santis M, Pont J, Klimpfinger M: Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery. Ann Surg Oncol 2006;13:75-85.

4.

Bachmann J, Michalski CW, Bergmann F, Buchler MW, Kleeff J, Friess H: Metastasis of rectal adenocarcinoma to the pancreas. Two case reports and a review of the literature. JOP 2007;8:214-222.

5.

Fritscher-Ravens A, Sriram PV, Krause C, Atay Z, Jaeckle S, Thonke F, Brand B, Bohnacker S, Soehendra N: Detection of pancreatic metastases by EUS-guided fine-needle aspiration. Gastrointest Endosc 2001;53:65-70.

6.

Klein KA, Stephens DH, Welch TJ: CT characteristics of metastatic disease of the pancreas. Radiographics 1998;18:369-378.

7.

Kiessling F, Boese J, Corvinus C, Ederle JR, Zuna I, Schoenberg SO, Brix G, Schmahl A, Tuengerthal S, Herth F, Kauczor HU, Essig M: Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring? Eur Radiol 2004;14:1226-1233.

8.

Richter GM, Simon C, Hoffmann V, DeBernardinis M, Seelos R, Senninger N, Kauffmann GW: Hydrospiral CT of the pancreas in thin section technique (in German). Radiologe 1996;36:397-405.

9.

Rumancik WM, Megibow AJ, Bosniak MA, Hilton S: Metastatic disease to the pancreas: evaluation by computed tomography. J Comput Assist Tomogr 1984;8:829-834.

10.

Biset JM, Laurent F, de Verbizier G, Houang B, Constantes G, Drouillard J: Ultrasound and computed tomographic findings in pancreatic metastases. Eur J Radiol 1991;12:41-44.

11.

Eelkema EA, Stephens DH, Ward EM, Sheedy PF 2nd: CT features of nonfunctioning islet cell carcinoma. AJR Am J Roentgenol 1984;143:943-948.

12.

Su D, Yamaguchi K, Tanaka M: The characteristics of disseminated tumor cells in pancreatic cancer: a black box needs to be explored. Pancreatology 2005;5:316-324.

13.

Vogel I, Kalthoff H, Henne-Bruns D, Kremer B: Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma. Pancreatology 2002;2:79-88.

14.

Hallscheidt PJ, Bock M, Riedasch G, Zuna I, Schoenberg SO, Autschbach F, Soder M, Noeldge G: Diagnostic accuracy of staging renal cell carcinomas using multidetector-row computed tomography and magnetic resonance imaging: a prospective study with histopathologic correlation. J Comput Assist Tomogr 2004;28:333-339.

15.

Flath B, Rickes S, Schweigert M, Lochs H, Possinger K, Wermke W: Differentiation of a pancreatic metastasis of a renal cell carcinoma from a primary pancreatic carcinoma by echo-enhanced power Doppler sonography. Pancreatology 2003;3:349-351.

16.

Stephens DH: CT of pancreatic neoplasms. Part I: Adenocarcinoma. Curr Probl Diagn Radiol 1997;26:59-80.

17.

Smith SL, Rajan PS: Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT. Clin Radiol 2004;59:26-38.

18.

Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr: Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 2002;224:764-768.

  Author Contacts

Prof. Dr. Peter Hallscheidt
Department of Diagnostic Radiology, University of Heidelberg, INF 110
DE-69120 Heidelberg (Germany)
Tel. +49 6221 563 6418, Fax +49 6221 565 730
E-Mail peter.hallscheidt@med.uni-heidelberg.de

  Article Information

Received: July 30, 2007
Accepted after revision: November 27, 2007
Published online: April 23, 2008
Number of Print Pages : 5
Number of Figures : 3, Number of Tables : 1, Number of References : 18

  Publication Details

Pancreatology

Vol. 8, No. 2, Year 2008 (Cover Date: May 2008)

Journal Editor: Urrutia R. (Rochester, Minn.)
ISSN: 1424-3903 (Print), eISSN: 1424-3911 (Online)

For additional information: http://www.karger.com/PAN

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.